Searched over 200M research papers
10 papers analyzed
Most studies suggest probiotics show potential in treating ulcerative colitis and pouchitis, while other studies indicate their benefits for Crohn's disease are inconclusive and require more research.
11 papers analyzed
18 papers analyzed
Inflammatory Bowel Disease (IBD) is a chronic condition characterized by inflammation of the gastrointestinal tract, including Crohn's disease (CD) and ulcerative colitis (UC). Recent research has explored the potential of probiotics—live microorganisms that confer health benefits—to manage IBD by modulating gut microbiota and immune responses.
General Efficacy in IBD:
Effectiveness in Ulcerative Colitis (UC):
Effectiveness in Crohn's Disease (CD):
Specific Probiotic Strains and Combinations:
Mechanisms of Action:
Probiotics show promise as an adjunctive treatment for IBD, particularly in managing ulcerative colitis. While they are generally safe and can help modulate gut microbiota and immune responses, more rigorous clinical trials are needed to establish their efficacy, optimal strains, dosages, and treatment protocols. The evidence for their use in Crohn's disease is less convincing, suggesting that probiotics may be more beneficial for UC than CD.
Most relevant research papers on this topic
prevention of PIVC related complications
Combining qualitative and quantitative data
How do we study and interpret the properties of interstellar dust and gas?
How can individuals assess their personal health and fitness levels to inform targeted improvements?
transactional leadership
supply chain management